Trulicity 0.75 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7NGV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,424
Award facts
- Contract value 100% obligated
- $1,424.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on January 2, 2026, by the Defense Logistics Agency for the supply of Trulicity 0.75 mg/0.5 ml pens valued at $1,424.16. The award represents a competitive, non-set-aside contract with firm fixed pricing and is scheduled for completion by January 5, 2026. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999 and extends through December 2026, serving as a comprehensive pharmaceutical support vehicle for military and federal healthcare systems.
The DLA Medical Supply Chain utilizes this prime vendor contract to procure a broad portfolio of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. Trulicity, a diabetes medication included in this delivery order, exemplifies the type of critical healthcare commodity supplied through AmerisourceBergen's federal contract portfolio to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract structure demonstrates the DLA's strategy of leveraging established vendor relationships to ensure reliable access to essential pharmaceuticals for military personnel and beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F7NGV?
SPE2DR26F7NGV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26F7NGV worth?
The government has obligated $1,424 on SPE2DR26F7NGV.
Is contract SPE2DR26F7NGV an order under another contract?
Yes. SPE2DR26F7NGV is a delivery order under SPE2DR25D7059, an indefinite delivery contract.
Was contract SPE2DR26F7NGV competed?
The extent of competition for SPE2DR26F7NGV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award